X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (886) 886
humans (849) 849
forkhead box protein m1 (582) 582
animals (553) 553
mice (448) 448
forkhead transcription factors - genetics (437) 437
forkhead transcription factors - metabolism (436) 436
foxm1 (408) 408
oncology (394) 394
cell line, tumor (377) 377
expression (366) 366
female (353) 353
cancer (327) 327
cell biology (295) 295
male (259) 259
gene expression (257) 257
cell proliferation (252) 252
cell cycle (240) 240
gene expression regulation, neoplastic (228) 228
biochemistry & molecular biology (216) 216
apoptosis (215) 215
proteins (211) 211
transcription factor (210) 210
transcription factors (203) 203
proliferation (185) 185
article (173) 173
forkhead box m1 (173) 173
progression (166) 166
signal transduction (165) 165
genetic aspects (160) 160
gene-expression (156) 156
middle aged (156) 156
research (156) 156
forkhead protein (153) 153
metastasis (152) 152
analysis (148) 148
prognosis (143) 143
forkhead box protein m1 - metabolism (141) 141
tumors (131) 131
cells (130) 130
forkhead box protein m1 - genetics (130) 130
kinases (120) 120
health aspects (118) 118
breast cancer (116) 116
phosphorylation (112) 112
down-regulation (111) 111
activation (110) 110
genes (110) 110
research article (110) 110
aged (109) 109
cell proliferation - drug effects (108) 108
development and progression (107) 107
adult (105) 105
up-regulation (104) 104
breast-cancer (103) 103
growth (103) 103
invasion (102) 102
mice, inbred c57bl (100) 100
multidisciplinary sciences (100) 100
immunohistochemistry (97) 97
medicine (97) 97
promoter regions, genetic (96) 96
biology (93) 93
transcription (93) 93
cell growth (91) 91
rna interference (91) 91
inhibition (89) 89
mice, knockout (88) 88
care and treatment (86) 86
medical prognosis (86) 86
target (85) 85
forkhead transcription factors - physiology (83) 83
transfection (83) 83
mice, nude (82) 82
transcription factor foxm1 (82) 82
forkhead transcription factors (81) 81
protein (80) 80
reverse transcriptase polymerase chain reaction (79) 79
angiogenesis (78) 78
apoptosis - drug effects (77) 77
genetics & heredity (77) 77
immunology (77) 77
tumorigenesis (77) 77
science (76) 76
studies (76) 76
medicine, research & experimental (74) 74
blotting, western (73) 73
forkhead transcription factors - biosynthesis (73) 73
physiological aspects (72) 72
cells, cultured (71) 71
inflammation (71) 71
protein binding (71) 71
rodents (71) 71
transcription factors - genetics (71) 71
antineoplastic agents - pharmacology (67) 67
forkhead transcription factors - antagonists & inhibitors (67) 67
mice, transgenic (67) 67
stem cells (67) 67
gene expression regulation, neoplastic - drug effects (66) 66
micrornas - genetics (65) 65
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncogene, ISSN 0950-9232, 09/2013, Volume 32, Issue 39, pp. 4634 - 4645
FOXM1 is implicated in genotoxic drug resistance but its role and mechanism of action remain unclear. Here, we establish that gamma H2AX foci, indicative of... 
breast cancer | epirubicin | BRIP1 | FOXM1 | DNA damage | resistance | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSCRIPTION FACTOR FOXM1 | BINDING DOMAIN | DOUBLE-STRAND BREAKS | MAMMALIAN-CELLS | BACH1 | CELL BIOLOGY | BREAST-CANCER CELLS | GENE | ONCOLOGY | GENETICS & HEREDITY | HOMOLOGOUS RECOMBINATION | PROGRESSION | Gamma Rays | MCF-7 Cells - radiation effects | Antibiotics, Antineoplastic - pharmacology | Humans | Neoplasm Proteins - physiology | Radiation Tolerance | Recombinant Fusion Proteins - physiology | Neoplasm Proteins - antagonists & inhibitors | Forkhead Transcription Factors - physiology | DNA Breaks, Double-Stranded | RNA, Messenger - biosynthesis | RNA Helicases - physiology | RNA Interference | RNA Helicases - biosynthesis | Fibroblasts | Female | RNA Helicases - genetics | Forkhead Transcription Factors - antagonists & inhibitors | Neoplasm Proteins - genetics | DNA-Binding Proteins - physiology | Neoplasm Proteins - biosynthesis | RNA, Small Interfering - pharmacology | DNA-Binding Proteins - genetics | MCF-7 Cells - drug effects | DNA, Neoplasm - drug effects | Fanconi Anemia Complementation Group Proteins | Animals | RNA, Neoplasm - biosynthesis | Histones - analysis | Recombinational DNA Repair - physiology | Mice | DNA Damage | DNA, Neoplasm - genetics | Forkhead Box Protein M1 | DNA-Binding Proteins - biosynthesis | Drug Resistance, Neoplasm - physiology | MCF-7 Cells - metabolism | Epirubicin - pharmacology | Care and treatment | Protein biosynthesis | Genetic aspects | Dosage and administration | Epirubicin | Research | Observations | Drug resistance | Cancer | Proteins | Chemotherapy | Breast cancer | Gene expression | DNA repair
Journal Article
The Journal of Pathology, ISSN 0022-3417, 12/2017, Volume 243, Issue 4, pp. 418 - 430
CCCTC‐binding factor (CTCF) is a DNA‐binding protein that interacts with a large number of highly divergent target sequences throughout the genome. It is... 
HCC | CTCF | TERT | FOXM1 | metastasis | chromatin immunoprecipitation | DNA METHYLATION | CTCF-BINDING | PATHOLOGY | MESENCHYMAL TRANSITION | GENOME | LIVER-CANCER | BREAST-CANCER CELLS | TELOMERE DYSFUNCTION | ONCOLOGY | MUTATIONS | PROGRESSION | Cell Proliferation | Humans | CCCTC-Binding Factor - genetics | Gene Expression Regulation, Neoplastic | CCCTC-Binding Factor - metabolism | Carcinoma, Hepatocellular - secondary | Liver Neoplasms - therapy | Telomerase - genetics | Transfection | RNA Interference | Time Factors | Carcinoma, Hepatocellular - genetics | Female | Liver Neoplasms - pathology | Telomerase - metabolism | Transcription, Genetic | Telomere - metabolism | Binding Sites | Telomere - genetics | Promoter Regions, Genetic | Liver Neoplasms - genetics | Signal Transduction | Neoplasm Invasiveness | Kaplan-Meier Estimate | Tumor Burden | Telomere Homeostasis | Hep G2 Cells | Disease-Free Survival | Animals | Mice, Nude | Liver Neoplasms - metabolism | Forkhead Box Protein M1 - genetics | Carcinoma, Hepatocellular - therapy | Mice, Inbred BALB C | Forkhead Box Protein M1 - metabolism | Carcinoma, Hepatocellular - metabolism | Cell Movement | Telomeres | Chromatin | Analysis | Genomics | Mice | Hepatoma | Genetic transcription | Metastasis | Telomerase | Protein binding | Cell proliferation | Animal models | Telomerase reverse transcriptase | Immunoprecipitation | RNA-directed DNA polymerase | Motility | Transcription | Pathogenesis | Liver | Hepatocellular carcinoma | Genomes | Metastases | Gene sequencing | Proteins | Liver cancer | Reporter gene | DNA-binding protein | Forkhead protein | Inhibition | Deoxyribonucleic acid--DNA | Invasiveness | Ribonucleic acid--RNA | Polymerase chain reaction | Depletion | Cell lines | Tumors | Original Papers | Original Paper
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2014, Volume 9, Issue 11, p. e113478
Aim: Deregulation of FOXM1 has been documented in various cancers. The aim of this study was to evaluate the role of FOXM1 in ovarian cancer tumorigenesis and... 
BREAST-CANCER | ACTIVATION | DIFFERENTIAL EXPRESSION | CARCINOGENESIS | INHIBITION | MULTIDISCIPLINARY SCIENCES | MITOTIC CATASTROPHE | CELL INVASION | DNA-DAMAGE | CENTROMERE-ASSOCIATED KINESIN | P53 | Immunohistochemistry | Paclitaxel - pharmacology | Prognosis | Follow-Up Studies | Apoptosis - drug effects | Humans | Ovarian Neoplasms - pathology | Drug Resistance, Neoplasm | Ovarian Neoplasms - mortality | Forkhead Transcription Factors - metabolism | Kinesin - genetics | Female | Forkhead Transcription Factors - antagonists & inhibitors | Antineoplastic Agents, Phytogenic - therapeutic use | Ovarian Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Ovarian Neoplasms - diagnosis | Kaplan-Meier Estimate | Down-Regulation - drug effects | Forkhead Transcription Factors - genetics | Paclitaxel - therapeutic use | G2 Phase Cell Cycle Checkpoints | Disease-Free Survival | Cell Line, Tumor | Antineoplastic Agents, Phytogenic - pharmacology | Forkhead Box Protein M1 | Neoplasm Staging | Cell Movement | Cancer patients | Analysis | Patient outcomes | Paclitaxel | Tumor proteins | Ovarian cancer | Deregulation | Ovarian carcinoma | Transcription | p53 Protein | DNA damage | Chemoresistance | Homeostasis | Multivariate analysis | Cell adhesion & migration | Surgery | Penicillin | Cell cycle | Forkhead protein | Tumorigenesis | Bioinformatics | Deoxyribonucleic acid--DNA | Gynecology | Gene expression | Obstetrics | Survival | Patients | Pathology | Chemotherapy | Cell death | Experimental design | Medical prognosis | Mutation | Cell migration | Cancer | Apoptosis | Deoxyribonucleic acid | DNA
Journal Article
Experimental and Therapeutic Medicine, ISSN 1792-0981, 07/2018, Volume 16, Issue 1, pp. 197 - 203
The present study aimed to investigate the expression of the forkhead box protein MI (FOXM1) in the placenta of patients with preeclampsia, and its effect on... 
Trophoblast | Forkhead box protein M1 | Vascular endothelial growth factor | Preeclampsia | MEDICINE, RESEARCH & EXPERIMENTAL | RNA | DNA-DAMAGE RESPONSE | preeclampsia | VEGF-A | FOXM1 | PREGNANCY | PATHWAY | forkhead box protein M1 | vascular endothelial growth factor | GROWTH | DYSFUNCTION | trophoblast
Journal Article
Journal Article
Journal Article
Journal Article
Oncology Reports, ISSN 1021-335X, 03/2017, Volume 37, Issue 3, pp. 1394 - 1400
Journal Article
Oncology Letters, ISSN 1792-1074, 2014, Volume 7, Issue 5, pp. 1711 - 1717
Casticin is an active ingredient derived from Fructus Viticis, a traditional Chinese medicine. This study aimed to investigate the role of forkhead box 03... 
Casticin | Breast cancer | Forkhead box O3 | Forkhead box protein M1 | Therapeutic targets | TARGET | HEPATOCELLULAR-CARCINOMA CELLS | ACTIVATION | ANGIOGENESIS | KINASE | BIM | PREVENTION | breast cancer | INDUCTION | FOXO TRANSCRIPTION FACTORS | LINES | ONCOLOGY | forkhead box protein M1 | therapeutic targets | forkhead box O3 | casticin
Journal Article
Oncology Reports, ISSN 1021-335X, 10/2018, Volume 40, Issue 4, pp. 1917 - 1926
An increasing body of evidence has indicated that microRNAs (miRNAs/miRs) may play an important role in tumourigenesis and tumour progression. Recent studies... 
Cell proliferation | MiRNA-320a | Forkhead box protein M1 | Cell invasion | Renal cell carcinoma | MIGRATION | APOPTOSIS | METASTASIS | cell proliferation | miRNA-320a | EPITHELIAL-MESENCHYMAL TRANSITION | BREAST-CANCER | renal cell carcinoma | INHIBITION | ONCOLOGY | forkhead box protein M1 | GENE-EXPRESSION | RESISTANCE | cell invasion | CARCINOMA | PROGRESSION | Kidney Neoplasms - genetics | Cell Proliferation | Prognosis | Follow-Up Studies | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Carcinoma, Renal Cell - genetics | Male | Kidney Neoplasms - metabolism | Case-Control Studies | Young Adult | Biomarkers, Tumor - metabolism | Adult | Female | Tumor Cells, Cultured | Carcinoma, Renal Cell - pathology | Neoplasm Invasiveness | Survival Rate | Xenograft Model Antitumor Assays | Carcinoma, Renal Cell - metabolism | Animals | Mice, Nude | Forkhead Box Protein M1 - genetics | Kidney Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Mice | Mice, Inbred BALB C | MicroRNAs - genetics | Forkhead Box Protein M1 - metabolism | Apoptosis | Cell Movement | Care and treatment | Transcription factors | MicroRNA | Kidney cancer | Development and progression | Genetic aspects | Gene expression | Health aspects | Animal experimentation | Cancer cells | Cancer | Mortality | Genes | Metastasis | Kinases | Patients | Cancer therapies | Data bases | Liver cancer | Angiogenesis | Cell growth | Cell cycle
Journal Article